Bolton LP’s Tenax Therapeutics TENX Stock Holding History

Bolton LP’s Portfolio TENX Stock Details TENX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-1	Closed	-$133K	–	134
2014 Q2	$133K	Hold	1	–	–	0.02%	121
2014 Q1	$180K	Buy	+1	New	+$198K	0.04%	148

Other funds holding TENX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

PRCM

Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BCM

Bluefin Capital Management New York $156M AUM 18.47% 1-Year Est. Return

Bolton LP's TENX Position: Q3 2014 in Review

Bolton LP sold out of Tenax Therapeutics (TENX) in Q3 2014, closing a stake of 1 share — an estimated $133K sold.

Bolton LP first reported a position in TENX in Q1 2014 and held it in 2 quarters. The position peaked at $180K in Q1 2014. 19 funds tracked by Wall St. Rank hold TENX as of Q3 2014.

Bolton LP reported no remaining Tenax Therapeutics position as of Q3 2014 after selling out during the quarter.
Bolton LP sold 1 Tenax Therapeutics share in Q3 2014, an estimated $133K.
Bolton LP first reported a position in Tenax Therapeutics in Q1 2014 and held it in 2 quarters.
Bolton LP's Tenax Therapeutics position peaked at $180K in Q1 2014.
19 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q3 2014.

Based on Bolton LP's 13F filing for Q3 2014, filed 14 Nov 2014.